tradingkey.logo
tradingkey.logo
Search

Kestra Medical Technologies Ltd

KMTS
Add to Watchlist
26.781USD
+0.501+1.91%
Market hours ETQuotes delayed by 15 min
1.56BMarket Cap
LossP/E TTM

More Details of Kestra Medical Technologies Ltd Company

Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.

Kestra Medical Technologies Ltd Info

Ticker SymbolKMTS
Company nameKestra Medical Technologies Ltd
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)
Number of employees330
Security typeOrdinary Share
Fiscal year-endMar 06
Address3933 Lake Washington Blvd Ne
CityKIRKLAND
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code98033
Phone14252798002
Website
Ticker SymbolKMTS
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)

Company Executives of Kestra Medical Technologies Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
280.02K
+21.67%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
119.65K
+21.08%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
40.06K
+62.97%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
--
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
--
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--

FAQs

Who are the top five shareholders of Kestra Medical Technologies Ltd?

The top five shareholders of Kestra Medical Technologies Ltd are: Mr. Brian Webster

How many institutions hold shares of Kestra Medical Technologies Ltd (KMTS)?

As of 2026Q1, 218 institutions hold shares of Kestra Medical Technologies Ltd, with a combined market value of approximately 60.76M, accounting for 104.08% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 5705735.00.